
Michael F Doubek MD Emerg Med, Inter Med
Critical Care Medicine
Sr. Clinician Emergency Medicine, and Internal Medicine, Board Certified
Join to View Full Profile
1114 3rd ave northGreat Falls, MT 59401
Dr. Doubek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 1984 - 1987
- SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 1984 - 1984
- Saint Louis University School of MedicineClass of 1983
Certifications & Licensure
- OR State Medical License 1985 - Present
- MT State Medical License 1990 - 2026
- American Board of Internal Medicine Internal Medicine
- AHAATLS, ACLS, NALS and PALS
Clinical Trials
- Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2011 Apr 01
- Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- 81 citationsIbrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.Gabriela Pavlasova, Marek Borsky, Václav Šeda, Katerina Cerna, Jitka Osičková
Blood. 2016-09-22 - 16 citationsA phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.Ian W. Flinn, Panayiotis Panayiotidis, Boris V. Afanasyev, Ann Janssens, Sebastian Grosicki
American Journal of Hematology. 2016-07-03 - 168 citationsA complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an Europea...Andy C. Rawstron, Claudia Fazi, A. Agathangelidis, N. Villamor, Rémi Letestu
Leukemia. 2016-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: